Pharmacologically manipulating endogenous cGMP generation in glioma cells through either stimulating pGC by ANP/BNP or blocking PDE by 3-isobutyl-1-methylxanthine/zaprinast caused significant inhibition of proliferation and colony formation of glioma cells. The gene discussed is PGC; the disease is glioma.